Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Amarillo › NPI 1659342061
Physician NPI deactivated

Allergy Arts LLP

Allergy Arts LLP was paid $3.55M by Medicaid between Jan 2018 and Nov 2024, across 59 billing codes. Its largest line is J0129, Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 25% of everything it billed.

33Billing provider infoALLERGY ARTS LLP
AMARILLO, TX 79124
33aNPI1659342061assigned 02/01/2006
28Total paid$3.55M
24GClaims85,535
24DCodes billed59
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Allergy & Immunology (Internal Medicine) Physician providers in Texas

Rank by total paid#1 of 6
Median peer was paid$878K
This provider vs. median4.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20184,644$8K
20195,618$8K
20206,844$225K
202118,241$874K
202218,438$1.13M
202320,278$902K
2024incomplete11,472$397K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 25% 369 282 $884K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 17% 1,408 1,246 $619K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 16% 10,359 9,405 $562K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials 15% 2,011 1,894 $536K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 5.5% 2,180 1,903 $196K
95117 4.5% 16,770 5,999 $159K
94728 2.8% 2,804 2,690 $101K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.4% 1,738 1,635 $86K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2.1% 524 506 $74K
96401 1.9% 990 636 $69K
80053 Comprehensive metabolic panel 1.1% 6,871 6,288 $40K
86235 1.1% 366 313 $40K
47 more codes
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 7,411 $33K
86140 <1% 6,953 $22K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,326 $20K
86225 <1% 1,068 $12K
99203 Doctor's office visit, new patient (routine) <1% 138 $12K
85652 <1% 6,819 $11K
86038 <1% 1,079 $11K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 932 $10K
86160 <1% 586 $7K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 352 $6K
76881 <1% 135 $6K
80074 <1% 147 $5K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 98 $4K
20611 <1% 94 $3K
94729 <1% 81 $3K
94726 <1% 56 $2K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 186 $1K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 112 $1K
82570 <1% 272 $1K
82728 <1% 85 $1K
81001 <1% 406 $1K
84156 <1% 311 $966.94
83970 <1% 30 $884.34
87400 <1% 63 $765.83
95012 <1% 265 $736.19
83516 <1% 90 $676.32
73110 <1% 23 $603.82
73130 <1% 23 $529.67
82607 <1% 45 $487.92
96415 <1% 16 $459.28
83550 <1% 54 $403.70
83540 <1% 68 $364.03
94010 <1% 13 $312.44
82746 <1% 29 $308.83
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 15 $250.08
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 1,545 $215.91
71046 Radiologic examination, chest; 2 views <1% 13 $200.14
86200 <1% 16 $163.20
82785 <1% 16 $159.95
86430 <1% 16 $154.80
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 19 $108.64
82550 <1% 16 $90.31
83735 <1% 12 $50.70
84100 <1% 15 $43.78
36415 Collection of venous blood by venipuncture <1% 7,985 $33.98
84550 <1% 16 $28.50
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 95 $16.01

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSAADEH, CONSTANTINE (PRESIDENT)